LCLAT1 抗体
(Lysocardiolipin Acyltransferase 1 (LCLAT1))
Acyl-CoA:lysocardiolipin acyltransferase. Possesses both lysophosphatidylinositol acyltransferase (LPIAT) and lysophosphatidylglycerol acyltransferase (LPGAT) activities. Recognizes both monolysocardiolipin and dilysocardiolipin as substrates with a preference for linoleoyl-CoA and oleoyl-CoA as acyl donors. Acts as a remodeling enzyme for cardiolipin, a major membrane polyglycerophospholipid. Converts lysophosphatidic acid (LPA) into phosphatidic acid (PA) with a relatively low activity. Required for establishment of the hematopoietic and endothelial lineages.
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| LCLAT1 抗体 (AA 296-324) (APC) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| LCLAT1 抗体 (AA 296-324) (PE) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| LCLAT1 抗体 (AA 296-324) (FITC) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| LCLAT1 抗体 (AA 296-324) (HRP) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| LCLAT1 抗体 (AA 296-324) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| LCLAT1 抗体 (C-Term) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| LCLAT1 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| LCLAT1 抗体 (C-Term) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| LCLAT1 抗体 | 人, 小鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 296-324
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 296-324
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 296-324
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 296-324
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 296-324
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 296-324, C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term, AA 303-332
Primary Antibody
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 296-324, C-Term
Latest Publications for our LCLAT1 抗体
: "Restoration of Mitochondrial Cardiolipin Attenuates Cardiac Damage in Swine Renovascular Hypertension." in: Journal of the American Heart Association, Vol. 5, Issue 6, (2016) (PubMed).
: "LPS impairs oxygen utilization in epithelia by triggering degradation of the mitochondrial enzyme Alcat1." in: Journal of cell science, Vol. 129, Issue 1, pp. 51-64, (2016) (PubMed).
: "Label-free quantitative proteomic analysis of right ventricular remodeling in infant Tetralogy of Fallot patients." in: Journal of proteomics, Vol. 84, pp. 78-91, (2013) (PubMed).
: "LPS impairs oxygen utilization in epithelia by triggering degradation of the mitochondrial enzyme Alcat1." in: Journal of cell science, Vol. 129, Issue 1, pp. 51-64, (2016) (PubMed).
: "Label-free quantitative proteomic analysis of right ventricular remodeling in infant Tetralogy of Fallot patients." in: Journal of proteomics, Vol. 84, pp. 78-91, (2013) (PubMed).
Aliases for LCLAT1 抗体
lysocardiolipin acyltransferase 1 (lclat1) 抗体lysocardiolipin acyltransferase 1 (LCLAT1) 抗体
lysocardiolipin acyltransferase 1 (Lclat1) 抗体
1agpat8 抗体
1AGPAT8 抗体
agpat8 抗体
AGPAT8 抗体
Agpat8 抗体
AGPATP8 抗体
AI181996 抗体
alcat1 抗体
ALCAT1 抗体
Alcat1 抗体
Gm91 抗体
HSRG1849 抗体
lclat1 抗体
LYCAT 抗体
lycat 抗体
Lycat 抗体
RGD1565906 抗体
UNQ1849 抗体
wu:fj17g04 抗体
zgc:77380 抗体
您还需要查找其他产品吗？
You are here:
